Company Overview
Founded in early 1990s by Dr. Richard Casey, CMX has been professionally and effectively conducting Phase I – IV pharmaceutical, biotech and medical device research. At CMX, we understand the importance of being proactive in project planning and implementation so that clinical projects are completed with the highest possible quality.
CMX offers clients a complete range of services for executing Phase I – IV clinical trials from the planning stages to the final report. CMX is able to achieve a high degree of cost savings by working collaboratively with their clients and assessing the most efficient means to achieve their goals.
Our services cover a broad range of study conduct activities that meet FDA, TPD and ICH standards. Our research efforts are segmented into clinical specialties to better serve our clients. Our commitment is to conduct medical research in an ethical, effective and efficient manner.
The basic principles for conducting a successful project adopted by CMX include proactive planning, open communication, clear delineation of responsibilities and close collaboration with our clients. We provide unlimited support from the initial project idea through to the final results.
The CMX client list includes small and global biopharmaceutical companies, community-based clinical investigators and local operating units of pharmaceutical companies.
